Plozalizumab Antibody
Plozalizumab (MLN-1202) is a humanized monoclonal antibody targeting CCR2 with demonstrated antitumor properties. It is utilized in research, including in vitro and in vivo studies, for investigating its role in malignancies such as melanoma.
Product Specifications
Product Name Alternative
MLN-1202, CCR2
Target
CCR
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation, Infectious Disease & Virology, Pharmacology & Drug Discovery
Concentration
2.73 mg/mL
Purity
96.40% (May vary between batches)
Molecular Weight
146.02 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog